About IMPRIME
Overview
IMPRIME is a forex broker registered in Hong Kong, with an official domain of im-forex.com. It was established on 16 March 2021, making it a relatively new entrant to the online trading space. The broker presents itself as a platform for retail forex and CFD trading, though public information about its operations remains scarce.
According to regulatory records, IMPRIME does not hold any known licences from financial authorities. This lack of oversight places the broker in a higher-risk category for traders who prioritise regulatory protection. The FXCanary Scam Risk Score of 51 out of 100 reflects an elevated risk profile, driven primarily by the absence of regulation and limited transparency.
Regulation and Safety
As of the latest review, IMPRIME operates without a licence from any recognised regulatory body. This means traders do not have access to typical safeguards such as negative balance protection, compensation schemes, or dispute resolution mechanisms provided by regulated brokers. The absence of regulation is a significant red flag, as unregulated brokers are not subject to minimum capital requirements or conduct standards.
Traders should exercise extreme caution when considering an unregulated entity. The lack of a regulatory framework increases the risk of unfair practices, including slippage, requotes, or difficulties in withdrawing funds. FXCanary strongly recommends verifying any broker's regulatory status before depositing funds.
Trading Instruments and Platforms
Based on the limited public information, IMPRIME likely offers forex trading on major, minor, and exotic currency pairs, as well as CFDs on indices, commodities, and cryptocurrencies. However, specific details about tradable instruments are not confirmed. The broker’s platform selection is also unclear, though it may offer MetaTrader 4 or 5, which are common among retail forex brokers.
Without reliable information from the official website or independent reviews, traders cannot verify the quality of execution, spreads, or available leverage. This lack of transparency makes it difficult to assess whether the trading environment meets industry standards.
Account Types and Funding
There is no verified information regarding account types, minimum deposits, or funding methods offered by IMPRIME. It is common for brokers in this category to provide multiple account tiers (e.g., standard, premium, VIP) with different spreads and leverage. Deposit and withdrawal methods typically include bank transfers, credit/debit cards, and e-wallets, but this cannot be confirmed for IMPRIME.
Traders should be wary of any broker that does not clearly disclose its fees, deposit processing times, or withdrawal policies. The absence of such details further contributes to the elevated risk score.
Customer Support and Company Background
IMPRIME is registered in Hong Kong, but the specific office address or contact details are not publicly available. The company’s registration date of 16 March 2021 indicates it has been operational for only a few years. Customer support channels, if any, are unknown, which could be a concern for traders needing assistance.
The limited company information makes it difficult to assess the broker’s financial stability or management team. Traders often rely on a broker’s transparency about its corporate structure as a sign of legitimacy; in this case, that transparency is lacking.
Conclusion and Trader Suitability
IMPRIME is an unregulated forex broker based in Hong Kong, founded in March 2021. Its elevated risk score of 51 underscores the dangers of trading with an entity that lacks regulatory oversight and has limited public information. The broker may suit only highly speculative traders who fully understand the risks of trading with an unregulated firm.
For most traders, particularly those who value capital protection and recourse in disputes, IMPRIME is not a suitable choice. FXCanary advises avoiding any unregulated broker until it can demonstrate compliance with recognised financial authorities and provide transparent operational details.
Overview compiled by FXCanary from regulatory records and public data. full IMPRIME review